ADRX Stock Chart & Stats
19.54
-0.40(-2.01%)
―
--
Day’s Range― - ―
52-Week Range18.50 - 23.21
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.88M
Market Cap
$2.04B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding102,200,905
10 Day Avg. Volume1,876,812
30 Day Avg. Volume1,876,812
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ADRX FAQ
What was ADARx Pharmaceuticals, Inc.’s price range in the past 12 months?
ADARx Pharmaceuticals, Inc. lowest stock price was 18.50 and its highest was 23.21 in the past 12 months.
What is ADARx Pharmaceuticals, Inc.’s market cap?
ADARx Pharmaceuticals, Inc.’s market cap is $2.04B.
When is ADARx Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ADARx Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is ADARx Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts ADARx Pharmaceuticals, Inc.’s price is currently Undervalued.
Does ADARx Pharmaceuticals, Inc. pay dividends?
ADARx Pharmaceuticals, Inc. does not currently pay dividends.
What is ADARx Pharmaceuticals, Inc.’s EPS estimate?
ADARx Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ADARx Pharmaceuticals, Inc. have?
ADARx Pharmaceuticals, Inc. has 102,200,905 shares outstanding.
What happened to ADARx Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ADARx Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in ADRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ADARx Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.